Core Viewpoint - The Hong Kong Innovative Drug 50 ETF (513780) experienced a decline of 1.45% on December 2, with a trading volume of 204 million yuan, indicating a downward trend in the fund's performance and investor sentiment [1] Group 1: Fund Performance - The fund's latest net asset value is calculated at 2.946 billion yuan [1] - Since its establishment on October 16, 2024, the fund has achieved a return of 70.17% [1] - Over the past month, the fund has recorded a return of -2.34% [1] Group 2: Fund Management - The fund is managed by Invesco Great Wall Fund Management Co., Ltd. [1] - The fund manager is Jin Huang [1] Group 3: Fund Size and Activity - The fund's shares decreased by 1 million, bringing the total shares to 1.731 billion [1] - In the last 20 trading days, the fund's shares have decreased by 8.25 million [1]
12月2日港股创新药50ETF（513780）份额减少100.00万份
Xin Lang Cai Jing·2025-12-03 01:11